Magle Chemoswed has received positive responses from regulatory agencies for market authorization of its range of advanced wound care products. This provides us with a clear pathway to registration of these developed products. As a strategic market for the Company this is an exciting and welcome development. The first line of products are expected to filed […]
About Gustaf Ström
This author has yet to write their bio.Meanwhile lets just say that we are proud Gustaf Ström contributed a whooping 3 entries.
Entries by Gustaf Ström
Magle Chemoswed expands its sales of Benserazide to a key customer as part of the Company strategy to enter emerging markets. The sale of Benserazide is testament to our strong commitment to make a difference in the field of healthcare and responsibly expanding our business to new and exciting markets.
Magle Chemoswed has filed multi-jurisdictional patent applications for protection for our range of surgical diagnostic devices. This is a first-in-class invention under which we have chemically bound enzymatic indicators to our SmartSpheres to be used by surgeons following suturing to identify enzymatic leakage.